Maravai LifeSciences Holdings, Inc. (MRVI) Q2 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good afternoon everyone and welcome to the Mara Vi Life Sciences second quarter 2025 earnings results conference call. At this time all participants are in a listen-only mode. Later you will have the opportunity to ask questions during the question and answer session. You may register to ask a question at any time by pressing star 1 on your telephone. Also today's call is being recorded and if you should need any operator assistance during the call today please press star 0 at any time. Now, at this time, I'd like to turn things over to Deb Hart, Senior Director, Investor Relations. Please go ahead, ma'am. Good afternoon, everyone. Thanks for joining us on our second quarter 2025 earnings call. The press release and slides accompanying today's call are posted on our website and available at investors.maravai.com. During today's call, management will make forward-looking statements and refer to GAAP and non-GAAP financial measures. it is possible that actual results could differ from management's expectations. We refer you to slide three for more detail on forward-looking statements and our use of non-GAAP financial measures. The press release provides reconciliations to the most directly comparable GAAP measures, and we also post reconciling schedules to the IR website. Please also refer to MARAVI's SEC filings for additional information on the risks and uncertainties that may impact our operating results performance, and financial condition. Now, I'll turn the call over to our Chief Executive Officer, Bernd Brust. Good afternoon, and thank you all for joining. I'm Bernd Brust, and I'm very pleased to be hosting my first earnings call as Marvi's CEO. I'd like to begin with my reasons for accepting the role as CEO, and in this context, frame for investors the incredib...